Nippon India Pharma Fund NAV Today

Nippon India Pharma Fund NAV is ₹638.72 as of 4 Nov 2026, up 11.9% over 1 year, 43 of 226 in Sectoral / Thematic Fund.

Nippon India Mutual Fund · Direct Plan, Growth option · NAV from AMFI, updated each business day

NAV

₹638.72

4 Nov 2026

1-year return

+11.9%

Category +3.34%

Category rank (1Y)

43 of 226

Sectoral / Thematic Fund

3-year return

+19.57%

a year, compounded

Returns

PeriodThis fundCategory averageDifferenceRank in category
1 month+1.64%+2.18%-0.54 pts—
6 months+10.13%+4.22%+5.91 pts—
1 year+11.9%+3.34%+8.56 pts43 of 226
3 years (a year)+19.57%+15%+4.57 pts34 of 139
5 years (a year)+14.67%+12.36%+2.31 pts31 of 99

3- and 5-year figures are compound annual returns; shorter periods are absolute.

NAV history

Oct 2021 · 322.16High 649.68 · Low 282.654 Nov 2026 · 638.72

₹5,000 a month in Nippon India Pharma Fund

What a monthly SIP started 1, 3 or 5 years ago is worth at the latest NAV.

SIP for 1 year

₹64,327

Invested ₹60,000

XIRR 15.64% a year

SIP for 3 years

₹2,11,329

Invested ₹1,80,000

XIRR 11.19% a year

SIP for 5 years

₹4,52,376

Invested ₹3,00,000

XIRR 16.87% a year

₹1 lakh invested at once

1 year ago

₹1,11,900

3 years ago

₹1,70,949

5 years ago

₹1,98,266

Direct vs Regular plan

The Regular plan pays a distributor commission out of the fund, so the same portfolio returns less. ₹1 lakh over 3 years grew to ₹1,63,176 in Direct and ₹1,58,854 in Regular, a difference of ₹4,322.

PeriodDirectRegularGap
1 year+13.87%+12.88%0.99 pts a year
3 years+17.73%+16.68%1.05 pts a year

Month-end NAVs to 30 Sept 2026.

How consistent it has been

1-year periods ahead of the Sectoral / Thematic Fund average

72%

36 rolling 1-year periods, month by month, over 3 years

Worst 1-year return in that time

-4.28%

Year to 30 Sept 2025

Other Sectoral / Thematic Fund schemes

NameNAV1Y3Y5Y
Nippon India Taiwan Equity FundNippon India Mutual Fund29.01+63.33%+52.01%—
Kotak Healthcare FundKotak Mahindra Mutual Fund17.82+27.21%——
HDFC Pharma and Healthcare FundHDFC Mutual Fund22.48+26.58%+31.62%—
Mirae Asset Healthcare FundMirae Asset Mutual Fund52.83+22.49%+25.01%+17.15%
SBI Automotive Opportunities FundSBI Mutual Fund13.43+22.41%——
HDFC Defence FundHDFC Mutual Fund30.29+22.25%+36.65%—
Bajaj Finserv Healthcare FundBajaj Finserv Mutual Fund12.11+21.63%——
WhiteOak Capital Pharma and Healthcare FundWhiteOak Capital Mutual Fund17.71+21.57%——

All Sectoral / Thematic Fund schemes ranked →

Plans and options

PlanOptionNAVScheme code
Direct PlanBonus Option638.72118758
Direct PlanGrowth Option638.72118759
Direct PlanIDCW Option174.80118756
Regular PlanBonus Option566.94102432
Regular PlanGrowth Option566.94102431
Regular PlanIDCW Option122.43102433

NAVs as of 4 Nov 2026. This page follows the Direct plan, Growth option.

Fund details

Fund house
Nippon India Mutual Fund
ISIN
INF204K01I50
AMFI scheme code
118759
NAV history from
29 Oct 2021

More schemes from Nippon India Mutual Fund

NameNAV1Y3Y5Y
Nippon India Taiwan Equity FundNippon India Mutual Fund29.01+63.33%+52.01%—
Nippon India Silver ETF FOFNippon India Mutual Fund28.09+23.13%+34.65%—
Nippon India Japan Equity FundNippon India Mutual Fund30.23+21.01%+22.56%+9.92%
Nippon India Gold Savings FundNippon India Mutual Fund56.10+16.34%+30.58%+22.74%
Nippon India US Equity Opportunities FundNippon India Mutual Fund46.55+12.03%+20.46%+11.04%
Nippon India Ultra Short Term FundNippon India Mutual Fund4,857.51+6.75%+7.54%+7.04%
Nippon India Arbitrage FundNippon India Mutual Fund31.25+6.65%+7.32%+6.85%
Nippon India CRISIL - IBX AAA Financial Services - Dec 2026 Index FundNippon India Mutual Fund11.58+6.58%——

Frequently asked questions

What is the NAV of Nippon India Pharma Fund today?

Nippon India Pharma Fund (Direct Plan, Growth option) has a NAV of ₹638.72 as of 4 Nov 2026, as published by AMFI. NAVs are declared once each business day.

What is the 1-year return of Nippon India Pharma Fund?

+11.9% over the year to 4 Nov 2026, against an average of +3.34% for Sectoral / Thematic Fund schemes. Past returns do not indicate future returns.

What would a ₹5,000 monthly SIP in Nippon India Pharma Fund be worth?

₹5,000 invested every month for the last 5 years (₹3,00,000 in total) is worth ₹4,52,376 at the latest NAV, an XIRR of 16.87% a year.

How much more does the Regular plan of Nippon India Pharma Fund cost?

Over 3 years, ₹1 lakh grew to ₹1,63,176 in the Direct plan and ₹1,58,854 in the Regular plan. The gap is the distributor commission, which the Regular plan pays out of the fund.

Which category is Nippon India Pharma Fund in?

Nippon India Pharma Fund is a Sectoral / Thematic Fund scheme from Nippon India Mutual Fund.

NAVs from AMFI; index levels from NSE. Returns are past performance and do not indicate future returns. For information only; not investment advice.